Table 1.

Characteristics of the two groups with conservative treatment and surgical treatment

Variables	Conservative treatment (n=83)	Surgical treatment (n=205)	p-value
Age	70.5±10.3	68.9±9.2	0.180*
Parity	3.9±1.7	3.7±1.6	0.276*
BMI	24.1±3.6	24.4±3.2	0.508*
Underlying disease
Cardiovascular
Hypertension	40 (48.2)	102 (49.8)	0.810†
Arrhythmia	5 (6.0)	7 (3.4)	0.336‡
Ischemic heart disease	4 (4.8)	13 (6.3)	0.785‡
Endocrine
Diabetes Mellitus	14 (16.9)	28 (13.7)	0.485†
Thyroid disease	3 (3.6)	9 (4.4)	1.000‡
Cerebrovascular disease	5 (6.0)	10 (4.9)	0.771‡
Symptom
Bearing down	51 (61.4)	154 (75.1)	0.020†
Protrusion mass	8 (9.6)	9 (4.4)	0.101‡
Spotting	3 (3.6)	10 (4.9)	0.763‡
Voiding difficulty	8 (9.6)	16 (7.8)	0.610†
Others	2 (2.4)	2 (1.0)	0.327‡
Stage
1	9 (10.8)	8 (3.9)	0.049‡
2	26 (31.3)	90 (43.9)	0.049†
3	16 (19.3)	78 (38.0)	0.002†
4	5 (6.0)	8 (3.9)	0.531‡
Unclassified	37 (44.6)	21(10.2)
Cystocele	60 (72.3)	187 (91.2)	<0.001†
Rectocele	27 (32.5)	144 (70.2)	<0.001†
Complication	11 (13.3)	36 (17.6)	0.370†

Values are presented as mean ± standard deviation or number (%).

^*p-value obtained by Student’s t-test

^†p-value obtained by chi-squared test

^‡p-value obtained by Fisher’s exact test.

# Stages were assessed using the Pelvic Organ Prolapse Quantitation (POP-Q) system.